Is IMPL undervalued or overvalued?

As of 2025-03-15, the Intrinsic Value of Impel Neuropharma Inc (IMPL) is -115.47 USD. This IMPL valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.24 USD, the upside of Impel Neuropharma Inc is -47,992.16%. This means that IMPL is overvalued by 47,992.16%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-115.47 - -115.47	-115.47	-47,992.16%
P/E	(350.56) - (534.39)	(376.43)	-156228.8%
DDM - Stable	(13.28) - (24.94)	(19.11)	-8025.1%
DDM - Multi	(3.59) - (5.54)	(4.37)	-1911.2%